OncoApp
source

OncoApp

(1)
Price
Free
Category
Medical
Last update
Jul 01, 2021
Publisher
pdlsolutions Contact publisher
View in store
Loading...

Ratings & Reviews performance

Ratings & Reviews performance provides an overview of what users think of your app. Here are the key metrics to help you identify how your app is rated by users and how successful is your review management strategy.

Number of reviews,
total
1
Avg rating,
total
⭐1.0
Loading...

Description

1495 chars

Protocols for haemato-oncological therapy OncoApp is a short and comprehensive summary of nearly 200 different chemotherapy protocols used daily in the treatment of 28 tumor entities all over the world. It was developed by oncologists for oncologists. The whole app includes hematological as well as solid tumor schemes. All chemotherapy protocols show the dose and application of each substance and are also supported by a graphical application schedule for one cycle each. Of course, the number of cycles and the day of repetition are mentioned. Additionally, important treatment depending comments are given if necessary (e.g. accompanying medication, dose reduction, etc.). And last but not least each protocol includes the original citation and 99% of all protocols are linked to the corresponding publication online – in most cases to PubMed. The protocols are updated continuously and new treatment strategies are included depending on approval. Activation is mandatory to use this App! Configuration of each protocol: 1. Overview Overview displays each substance, day(s) of therapy, dosage, diluent and volume (if necessary), time for and the route of application. 2. Scheme Scheme displays one complete cycle per protocol with the days of application marked. Additionally the day of repetition and the number of cycles are given. 3. Comment Within comment all notes for each protocol are given and the original citation (with the corresponding link to the PubMed) is included.

Screenshots

https://is3-ssl.mzstatic.com/image/thumb/Purple115/v4/f2/1c/51/f21c51ef-c40e-ea56-8731-5b30d5b7e44c/mzl.nmqcxbgh.png/1242x2208bb.pnghttps://is2-ssl.mzstatic.com/image/thumb/Purple115/v4/fa/95/59/fa955901-c06e-38a7-d36d-736c6742d7f5/mzl.socqaoqc.png/1242x2208bb.pnghttps://is5-ssl.mzstatic.com/image/thumb/Purple115/v4/ad/61/1c/ad611c32-c898-4067-854f-b4f939ba996e/pr_source.png/1242x2208bb.pnghttps://is1-ssl.mzstatic.com/image/thumb/Purple125/v4/38/e7/eb/38e7eb81-bb49-86ba-963f-ee86de918595/pr_source.png/1242x2208bb.pnghttps://is3-ssl.mzstatic.com/image/thumb/Purple115/v4/f2/a6/6d/f2a66d0f-5ff7-9c12-31ba-397c19b991be/pr_source.png/1242x2208bb.png
Loading...
Loading...

Find growth insights on our blog

React to user feedback and market trends faster